Cinna

Cinna

cinnarizine

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Concise Prescribing Info
Contents
Cinnarizine
Indications/Uses
Symptomatic treatment of nausea & vertigo due to Meniere's disease & other labyrinthine disturbances, prevention of motion sickness; management of peripheral arterial disease.
Dosage/Direction for Use
Adult 15-30 mg tds. Childn 5-12 yr ½ adult dose. Motion sickness 1 tab 2 hr before start of journey & thereafter ½ tab 8 hrly.
Administration
Should be taken with food.
Special Precautions
Hypotension. May affect ability to drive or operate machinery. Pregnancy.
Adverse Reactions
Drowsiness, allergic skin reactions, fatigue.
Drug Interactions
Alcohol.
MIMS Class
Peripheral Vasodilators & Cerebral Activators / Antivertigo Drugs
ATC Classification
N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.
Presentation/Packing
Form
Cinna tab 25 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in